Symbol="FENC"
AssetType="Common Stock"
Name="Fennec Pharmaceuticals Inc"
Description="Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina."
CIK="1211583"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="217924000"
EBITDA="-13009000"
PERatio="None"
PEGRatio="None"
BookValue="-0.278"
DividendPerShare="0"
DividendYield="0"
EPS="-0.98"
RevenuePerShareTTM="0.122"
ProfitMargin="0"
OperatingMarginTTM="-7.57"
ReturnOnAssetsTTM="-0.742"
ReturnOnEquityTTM="-10.06"
RevenueTTM="3212000"
GrossProfitTTM="1449000"
DilutedEPSTTM="-0.98"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="829.84"
PriceToBookRatio="92.32"
EVToRevenue="722.26"
EVToEBITDA="-12.04"
Beta="0.236"
num_52WeekHigh="10.85"
num_52WeekLow="6.23"
num_50DayMovingAverage="8.45"
num_200DayMovingAverage="8.81"
SharesOutstanding="26419500"
DividendDate="None"
ExDividendDate="None"
symbol="FENC"
open="8.56"
high="8.56"
low="8.05"
price="8.20"
volume="70248.00"
latest_trading_day="2023-07-21"
previous_close="8.51"
change="-0.31"
change_percent="-3.6428%"
aroon_positive_momentum_days="31"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="114179"
Change_recent_avg="0.01"
Delta_recent_avg="0.44"
Variance_recent_avg="0.22"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0049.jpeg"
image_negative_thumbnail_id_2="124"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0052.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="641"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0067.jpeg"
image_positive_thumbnail_id_2="999"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0161.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
